Nursing Pharmacology: Autonomic Pharmacology Adrenergic Drugs
CNS stimulant (releasing biogenic nerve terminal amines):
Respiratory center
Mood elevation
Decreased perception of fatigue
Other effects: headache, palpitations, dysphoria
Appetite suppression
Weight loss due to decrease food intake
Psychological tolerance/dependence
Indirect acting sympathomimetic
Toxicity:
CNS: restlessness, tremor, irritablity, insomnia, aggressiveness, anxiety, panic, suicidal ideation, etc.
Cardiovascular: arrhythmias, hypertension or hypotension, angina
GI: dry mouth, anorexia, vomiting, diarrhea, cramping
Treatment:
Urinary acidification by ammonium chloride
Hypertension: nitroprusside or α adrenergic receptor antagonist
CNS: sedative-hypnotic drugs
Therapeutic Use:
Narcolepsy
Obesity
Attention-deficit hyperactivity disorder
Methylphenidate (Ritalin)
Mild CNS stimulant, chemically related to amphetamine
Effects more prevalent on mental than motor activities
General pharmacological profile similar to amphetamine
Major Therapeutic Use:
Narcolepsy
Attention-deficit hyperactivity disorder
α and ß adrenergic receptor agonist
Indirect sympathomimetic also, promoting norepinephrine release
Non-catechol structure, orally active
Pharmacological effects:
Increases heart rate, cardiac output
Usually increases blood pressure
May cause uriniary hesitancy due to stimulation of a smooth muscle receptors in bladder base.
Bronchodilation: ß adrenergic receptor response
Limited Clinical Use due to better pharmacological alternatives (asthma, heart block, CNS stimulation)
Vasoconstrictors for Nasal Mucosal Membranes and for the Eye
Propylhexedrine
Naphazoline (Privine)
Retrahydrozoline (Visine)
Oxymetazoline (Afrin)
Phenylpropanolamine (Propagest)
Pseudoephedrine (Sudafed)
Ethylnorepinephrine (Brokephrine)
Xylometzoline (Otrivin)
Hoffman, B.B and Lefkowitz, R.J, Catecholamines, Sympathomimetic Drugs, and Adrenergic Receptor Antagonists, In, Goodman and Gillman's The Pharmacologial Basis of Therapeutics, (Hardman, J.G, Limbird, L.E, Molinoff, P.B., Ruddon, R.W, and Gilman, A.G.,eds) TheMcGraw-Hill Companies, Inc.,1996, pp.216-219
Use (very limited) as appetite suppressant with high abuse potential
Fenfluramine: appetite suppressant; cardiotoxic (withdrawn from market)
Methylphenidate (Ritalin) similar but with fewer peripheral effects, useful in Attention Deficit Disorder.